MIRA INFORM REPORT

 

 

Report Date :

01.12.2014

 

IDENTIFICATION DETAILS

 

Name :

APEX PHARMA LTD

 

 

Formerly Known As :

RIBAK PHARMACEUTICALS LTD

 

 

Registered Office :

House # 06, Road # 137, Block # SE (D), Gulshan, Dhaka-1212

 

 

Country :

Bangladesh

 

 

Date of Incorporation :

29.08.2014

 

 

Com. Reg. No.:

C-17808

 

 

Legal Form :

Private Company

 

 

Line of Business :

Manufacturer and Distributor of Tablet, Capsules, Injectable, Semisolid, Liquid and Ophthalmic Formulations    

 

 

No. of Employees :

355

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Bangladesh

B1

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BANGLADESH - ECONOMIC OVERVIEW

 

Bangladesh's economy has grown roughly 6% per year since 1996 despite political instability, poor infrastructure, corruption, insufficient power supplies, slow implementation of economic reforms, and the 2008-09 global financial crisis and recession. Although more than half of GDP is generated through the service sector, almost half of Bangladeshis are Employed in the agriculture sector with rice as the single-most-important product. Garment exports, the backbone of Bangladesh’s industrial sector and 80% of total exports, surpassed $21 billion last year, 18% of GDP. The sector has remained resilient in recent years amidst a series of factory accidents that have killed over 1,000 workers and crippling strikes that shut down virtually all economic activity. Steady garment export growth combined with remittances from overseas Bangladeshis, which totaled almost $15 billion and 13% of GDP IN 2013, are the largest contributors to Bangladesh’s current account surplus and record foreign exchange holdings.

 

Source : CIA

EXECUTIVE SUMMARY

 

                                                IDENTIFICATION DETAILS

 

Correct company Name

:

Apex Pharma Ltd

Company Privies Name

:

Ribak Pharmaceuticals Ltd

Head Office

:

House # 06, Road # 137, Block # SE (D), Gulshan, Dhaka-1212,

 Bangladesh                                                                                    

Tel No

:

88-02-9863026, 9856717

Fax No

:

88-02-8856743

E-mail

:

info@apexpharmabd.com

Website

:

www.apexpharmabd.com

Date/ Year of Incorporation

:

29/08/2014

Incorporation No.

:

C-17808

Legal Form (General)

:

 Public Listed Co        Public (but not listed)   Private Co   State-owned Co

 Sole Proprietorships  Partnership                     Not Registered

 others (please specify) ________________

Legal form (Specific)

:

LTD   CORP    INC  CO    

 others (please specify) ________________

Issuing Authority

:

Registrar of Joint Stock Companies & Firms   City Corporation

 Municipal Administration                                   Union Council

 Cantonment Board                                              Chief Controller of  Import & Export (CCIE)

 

 

FINANCIALS- SUMMARY

      Year

Turnover/ Sales

 Assets

     Income

July’ 12~June’ 13

BDT 443.05 Million

BDT 1237.30  Million

BDT 24.31  Million

July’ 13~June’ 14

BDT 510.85  Million

BDT 1395.30 Million

BDT 28.05  Million

Exchange Rate

USD1-Tk. 77.8200

EUR 1- Tk. 100.2711

GBP 1- Tk.118.5354

AUD 1 - Tk.82.8563

JPY 1 - Tk.0.9286

CAD 1 - Tk.80.1887

SEK 1 - Tk.12.2870

SGD 1 - Tk.65.3045

CNH 1 - Tk.12.8399

 

 

 

 

 

 

 

FULLCHECK REPORT DETAILS

 

                                                             Information Parted By

 

 

 

Name

:

Ms. Lalala Khan

Designation

:

Officer

Contract No

:

-

 

                                                               Locations Details

Operating Address

:

House # 06, Road # 137, Block # SE (D), Gulshan, Dhaka-1212, Bangladesh                                                                                    

Tel No

:

88-02-9863026, 9856717

Fax No

:

88-02-8856743

E-mail

:

info@apexpharmabd.com

Website

:

www.apexpharmabd.com

 

Location :

: Owned

 

 

Rented

Ö

 

Leased

 

Area

2800

Sq. ft.

 

Type of Office :

  :       Commercial Office Bldg.

 

 

Semi-commercial office Bldg.

 

     

Retail shop

 

 

Industrial Park

 

     

 

Business Center

 

 

Home Office

 

     

 

Residential Bldg.

Ö

 

 

 

 

 

 

Factory:

 

 

Address

:

Shafipur,Kaliakoir, Gazipur, Bangladesh 

Tel No

:

88-06822-51305

Fax No

:

88-06822-51306

 

Location :

   Owned

Ö

 

Rented

 

 

Leased

 

Area

5

Acores

 

Branches:

 

 

Address

:

Nil

Tel No

:

Nil

Fax No

:

Nil

 

Employee:

 

 

 

No. of Employees 

 

In Office

:

55

In Factory

:

300

In Branch:

:

 

Total

:

355

Details:

 

                    

 

 

 

OWNERSHIP/SHAREHOLDERS

 

         Names of Shareholders

                      No. of Share     

Apex Enterprises Limited

219320

Mr. Syed Nasim Manzur

582240

Mr. Niloufer  Manzur

282240

Mr. Syed Manzur Elahi

583240

 

 

DIRECTORS

 

Name

Designation

Mr. Syed Nasim Manzur

Managing Director

Mr. Syed Manzur Elahi

Director

Mr. Niloufer  Manzur

Director

Mr. Dilip Kajuuri (Nominated by Apex Enterprises Ltd)

Director

 

 

MANAGEMENT

 

Name

:

Ms. Lalala Khan

Job Description

:

Officer

Nationality

:

Bangladeshi

Email address

:

N/A

Other details

:

N/A

 

 

 

 

 

BUSINESS OPERATIONS

 

Nature of Activity       :

Manufacturer

Ö

Trader

 

Dealer

 

Distributor

Ö

 

 

 

Exporter

 

Importer

 

Services

 

Others

 

 

Range of Products:

 

Products

:

Tablet, Capsules, Injectable, Semisolid, Liquid And Ophthalmic Formulations    

Production Capacity

:

N/A

Last Year Production

:

N/A

 

Trading Terms:

 

Purchasing Terms:

L/C

Ö

Cash

 

Others

 

 

 

Credit :

 

30 days

 

60 days

Ö

90 days

 

 

days

 

Selling Terms      :

L/C

 

Cash

Ö

Others

 

 

 

Credit :

Ö

30 days

 

60 days

 

90 days

 

 

days

 

 

DETAILED DATA

 

Trade Reference & Related Parties

:

 

Overseas Clients

:

N/A

Local Clients

:

N/A

 

Overseas Suppliers

:

N/A

Local Suppliers

:

N/A

 

Trade Markets

:

 

Exports

:

N/A

 

Imports

:

China, India, Japan, Germany, India

 

 

 

Brand Name

:

Nil

Certified

:

Nil

Auditors

:

 N/A

Operation Status

:

Active

Member

:

 Bangladesh Drug Association

 

 

CAPITAL STRUCTURE

 

Authorized Capital

:

BDT 1000 million

 

Paid-up Capital

:

BDT 16,67,04,000

No. of Shares

:

1667040

Share Value

:

BDT 100.00Each

Main Assets

:

BDT 1395.30 Million

 

 

 

FINANCIAL STATEMENT- DETAILED

 

The subject company don’t submit update financial figure to local registry office.

 

 

 

ASSOCIARES/SUBSIDIARIES/ RELATED PARTIES

 

Sister Concerns

:

Grey Advertising Bangladesh Limited

Apex Pharmaceuticals ltd.

Apex Footwear ltd.

Galass Apex Company

Apex Enterprise

Apex Adelchi Footwear Ltd

Apex Adelchi Footwear Limited.

Quantum Consumer Solution Limited

Grey Advertising Bangladesh Limited.

Apex Tannery Limited

Quantum Market Research BD Limited.

Mutual Trust Bank Limited.

Pioneer Insurance Company Limited.

Blue Ocean Footwear Ltd

Apex Investments Ltd

Apex Hotels Limited

Subsidiary

:

N/A

Name of  The Group

:

Apex Group

 

 

BANKING

 

Bank Name  

:

Prime Bank Ltd

United Commercial bank Ltd

The City Bank Ltd

Brac Bank Ltd

 

 

ADVERSE DATA MONITORING

 

Dishonored Checks           

 

:     

No Record Found         

Debt

 

:

No Record Found

Litigation  

                   

:

Clear         

Performance Defaults

 

:

No Record Found         

Adverse Local Media Coverage/ Adverse Filling History

:

No Record Found

 

 

SITE VISIT COMMENTARY

 

Our representative visited the subject company Head Office which is situated at House # 06, Road # 137, Block # SE (D), Gulshan, Dhaka-1212, Bangladesh. It is situated at residential area & their office is decorated by modern furniture.                                                                                    

 

 

GENERAL COMMENTS

 

Subject is mainly engaged in Manufacturer & Distributors of pharmaceuticals products. The subject company maintains acceptable business volume. Based on the financial statements, SC’s financial performance appears to be average.

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.61.97

UK Pound

1

Rs.97.37

Euro

1

Rs.77.16

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

NIT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.